Pharma Pulse 1/28/25: Exploring Biopharma's Dealmaking Terrain, Pharmacovigilance in Digital Therapeutics & more

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

The Evolving Role of Pharmacovigilance in Digital Therapeutics

Digital therapeutics (DTx), a novel evidence-based software approach, is revolutionizing health care by delivering personalized treatments. Pharmacovigilance ensures DTx safety but faces challenges such as data privacy and standardization.

Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
Senior Care Partners (PACE) Advances Elderly Patient Safety with DoseMeRx

DoseMe announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the Curve (AUC) guidelines. This advancement ensures standardized, efficient dosing practices across its team of three pharmacists, who manage a patient population of 600 outpatients.

UpScriptHealth on LinkedIn

Our partnerships withe#pharmaceutical and #medicaldevice companies have been doubling YoY, and we expect exponential growth in 2025. In part 3 of our founder & CEO Peter Ax's interview with Miranda Schmalfuhs at Pharmaceutical Executive, he sheds light on why more pharmaceutical and medical device companies are seeking out direct-to-patient #telehealth solutions.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs